PCR Course webcasts, videos & slides

Consult this session presented by M. Joner, W. Wijns and M.K.Y. Lee if you want to find out more about the best indication for patient selection in 2017, ultrathin, bioresorbable polymer sirolimus-eluting stents vs thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisatio; the new update on Dual Antiplatelet Therapy (DAPT) VALIDATE-SWEDEHEART, TROPICAL-ACS and RE-DUAL PCI from the ESC 2017 and more...

Chairpersons: A. Latib , O. Mendiz

Objectives: To learn about contemporary treatment strategies for left main coronary artery bifurcation lesions and to reflect on practical cases, to learn from state-of-the-art imaging on stent behavior in bifurcation, to learn about usefulness of novel generation DES dedicated to large vessel treatment

Do we really have a new device that reproduces a surgical technique for mitral repair? Join F. Maisano, surgeon and interventionalist, R. S. von Bardeleben interventionalist and echocardiographer and A. Vahanian, interventional cardiologist as they explore this “cutting edge” system in valvular repair. Learn about current data which shows sustainable reduction in annulus size or the learning curve and role of CT scans in patient selection. Imaging is discussed along with a review of new imaging technologies that help make these interventions possible. Can this be translated this to the tricuspid space and tricuspid ring? A dream…or reality? Watch here…

Chairpersons: F. Maisano , A.S. Petronio

Objectives: To discuss complex situations in transcatheter aortic valve intervention with experts commenting cases, to discuss technical points to leverage specific features of the CoreValve Evolut R system to achieve superior outcomes

An increasingly proven re-positionable TAVI device offering a true alternative today? Join M. Götberg, T. Feldman and L. Sondergaard as they discuss emerging results from a recent key international trial underlining the safety, efficacy and non-inferiority of the Lotus valve in a high-risk population. Listen as they tease out the meaning behind these results concerning stroke, paravalvular leak and pacemaker use in high- and lower-risk groups. What are we seeing in the newer-generation Lotus device and what design enhancements are we looking for in the future? How important is experience in implantation techniques? What should we expect from upcoming trials? Watch now...

Chairpersons: M.K.Y. Lee , R. Waksman

Objectives: To learn how Magmaris affects thrombogenicity, to discuss on the best implantation techniques, to review optimal indications and patient selection for Magmaris use

Why has this been called “the year” of Left Main interventions? A. Latib, O. Mendiz and Z. Ghazzal review the new maturity of an intervention which pioneer A. Grüntzig attempted years ago. Learn about the compelling data today from the EXCEL study showing non-inferiority of the endovascular approach and discover what is unique about the ongoing European Bifurcation Club’s EBC Main trial. Find out how these studies can impact on indications and eventual changes in future guidelines. From new devices – sizes and the choice of 1 or 2 stents – to experience and improved techniques, the critical elements of strategy and the choice of imaging for planning, optimisation and outcome: you’ll find the details here…